The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The 2022 Tandem Meetings | Unmet needs for extramedullary disease in multiple myeloma
Radhika Bansal, MBBS, Mayo Clinic, Rochester, MN, outlines current unmet needs in extramedullary disease (EMD) in multiple myeloma. Dr Bansal underlines the need for large randomized clinical trials to define clear guidelines for the treatment and follow-up of patients with EMD, as well as to evaluate the safety and efficacy of available treatment options. It is also critical to explore new more effective treatment strategies for this patient population. This interview took place at the Transplantation & Cellular Therapy (TCT) Meetings of ASTCT™ and CIBMTR® 2022 in Salt Lake City, Utah.
